The data presented indicate that it potently enhances NK cell mediated control of HER2-expressing ovarian cancer in vitro and successfully inhibits tumor growth in a murine xenograft model that accommodates the engraftment of human ovarian cancer cells and human NK cells. The gene discussed is ERBB2; the disease is ovarian carcinoma.